| Plasma p-tau231 and p-tau217 as state markers of amyloid-β pathology in preclinical Alzheimer’s disease M Milà-Alomà, NJ Ashton, M Shekari, G Salvadó, P Ortiz-Romero, ... Nature Medicine 28 (9), 1797-1801, 2022 | 236 | 2022 |
| Plasma and CSF biomarkers in a memory clinic: head‐to‐head comparison of phosphorylated tau immunoassays NJ Ashton, A Puig‐Pijoan, M Milà‐Alomà, A Fernández‐Lebrero, ... Alzheimer's & Dementia 19 (5), 1913-1924, 2023 | 89 | 2023 |
| Epigallocatechin-3-gallate improves cardiac hypertrophy and short-term memory deficits in a Williams-Beuren syndrome mouse model P Ortiz-Romero, C Borralleras, M Bosch-Morató, B Guivernau, G Albericio, ... PLoS One 13 (3), e0194476, 2018 | 31 | 2018 |
| A novel ultrasensitive assay for plasma p‐tau217: Performance in individuals with subjective cognitive decline and early Alzheimer's disease F Gonzalez‐Ortiz, PCL Ferreira, A González‐Escalante, L Montoliu‐Gaya, ... Alzheimer's & Dementia, 2023 | 17 | 2023 |
| Altered neocortical dynamics in a mouse model of Williams–Beuren Syndrome M Dasilva, A Navarro-Guzman, P Ortiz-Romero, A Camassa, ... Molecular Neurobiology 57, 765-777, 2020 | 16 | 2020 |
| Stenosis coexists with compromised α1-adrenergic contractions in the ascending aorta of a mouse model of Williams-Beuren syndrome F Jimenez-Altayo, P Ortiz-Romero, L Puertas-Umbert, AP Dantas, B Pérez, ... Scientific Reports 10 (1), 889, 2020 | 16 | 2020 |
| Cannabinoid signaling modulation through JZL184 restores key phenotypes of a mouse model for Williams–Beuren syndrome A Navarro-Romero, L Galera-López, P Ortiz-Romero, A Llorente-Ovejero, ... Elife 11, e72560, 2022 | 11 | 2022 |
| Co-Treatment With Verapamil and Curcumin Attenuates the Behavioral Alterations Observed in Williams–Beuren Syndrome Mice by Regulation of MAPK Pathway and Microglia Overexpression P Ortiz-Romero, A González-Simón, G Egea, LA Pérez-Jurado, ... Frontiers in Pharmacology 12, 670785, 2021 | 9 | 2021 |
| Publisher Correction: Plasma p-tau231 and p-tau217 as state markers of amyloid-β pathology in preclinical Alzheimer’s disease M Milà-Alomà, NJ Ashton, M Shekari, G Salvadó, P Ortiz-Romero, ... nature medicine 28 (9), 1965-1965, 2022 | 7 | 2022 |
| Clinical performance and head-to-head comparison of CSF p-tau235 with p-tau181, p-tau217 and p-tau231 in two memory clinic cohorts J Lantero-Rodriguez, A Vrillon, A Fernández-Lebrero, P Ortiz-Romero, ... Alzheimer's Research & Therapy 15 (1), 48, 2023 | 6 | 2023 |
| Chlorzoxazone, A BKCa Channel Agonist, Rescues The Pathological Phenotypes Of Williams-Beuren Syndrome In A Preclinical Model M Piquemal, N Abdulkarim-Abdalla, P Ortiz-Romero, V Lemaire-Mayo, ... bioRxiv, 2020.12. 22.423977, 2020 | 2 | 2020 |
| The Combined Treatment of Curcumin with Verapamil Ameliorates the Cardiovascular Pathology in a Williams–Beuren Syndrome Mouse Model N Abdalla, P Ortiz-Romero, I Rodriguez-Rovira, LA Pérez-Jurado, G Egea, ... International Journal of Molecular Sciences 24 (4), 3261, 2023 | 1 | 2023 |
| Study of molecular causes underlying Williams-Beuren syndrome phenotype through the development of novel therapeutic approaches P Ortiz Romero Universitat Pompeu Fabra, 2019 | | 2019 |
